BNAR Syndrome (Bifid Nose With or Without Anorectal and Renal Anomalies)

BNAR Syndrome (Bifid Nose With or Without Anorectal and Renal Anomalies) is a very rare, inherited condition present at birth. The key feature is a split or “bifid” tip of the nose. Some people also have problems of the anus and rectum (such as a front-placed anus, a narrow rectum, or a blocked rectum), and some have kidney problems (such as one or both kidneys not forming fully). Thinking and learning are usually normal. The look and the mix of problems can be different from person to person, even within the same family. BNAR is usually caused by changes (mutations) in a gene called FREM1, and it is passed down in an autosomal recessive way. PubMed+3rarediseases.info.nih.gov+3Orpha+3

BNAR syndrome stands for “Bifid Nose with or without Anorectal and Renal anomalies.” People with BNAR are born with a split or wide nasal tip (bifid nose). Some also have problems with the anus/rectum (for example, the anus may be misplaced, narrowed, or not formed) and kidney/urinary tract problems (for example, one kidney missing or kidneys that did not develop normally). Growth and learning are usually normal. BNAR is linked to changes in the FREM1 gene, which helps the body build the “basement membrane” that shapes tissues in early life. BNAR looks related to Manitoba oculotrichoanal (MOTA) syndrome and to some congenital kidney/urinary tract anomalies. Care focuses on surgery for structure problems and long-term follow-up for bowel and kidney health. ScienceDirect+4Orpha+4rarediseases.info.nih.gov+4

Doctors noticed families in which several people had a bifid nose together with anorectal and/or kidney defects. Later studies showed that harmful changes in both copies of FREM1 explain the condition in those families. Since 2002, only a small number of families have been reported in the medical literature, so the syndrome is considered extremely rare. OUP Academic+1

---

Other names

• BNAR syndrome

• Bifid nose with or without anorectal and renal anomalies

• Bifid nose, renal agenesis and anorectal malformations syndrome (describes the classic triad)

• OMIM 608980; MONDO:0012165 (catalog identifiers used by databases) malacards.org+1

---

Types

Because people can show different mixes of features, doctors often group BNAR by involvement pattern rather than strict subtypes:

1. Nasal-only pattern: A bifid or wide nasal tip without anorectal or kidney anomalies (this can occur and has been reported). Wiley Online Library

2. Nasal + anorectal pattern: Bifid nose with defects such as front-placed anus, rectal narrowing, or atresia. rarediseases.info.nih.gov

3. Nasal + renal pattern: Bifid nose with kidney problems such as renal dysplasia or agenesis (one or both kidneys under-developed or missing). Orpha

4. Classic triad pattern: Bifid nose plus anorectal and renal anomalies. malacards.org

5. Genetically confirmed BNAR: Clinical features and pathogenic variants in FREM1 on testing. NCBI

BNAR looks related (but is distinct) to Fraser syndrome and Manitoba oculotrichoanal (MOTA) syndrome, which are also linked to the FRAS/FREM protein network. BNAR usually does not include the eye and hair findings typical of MOTA. rarediseases.info.nih.gov+1

---

Causes

BNAR is a genetic condition. The main cause is harmful changes in both copies of the FREM1 gene. Below are ways this can happen, written as specific genetic/mechanistic causes or recognized contributing factors. (Items 1–12 are direct genetic causes; 13–20 are established patterns or contributors that raise risk or shape expression.)

1. Biallelic loss-of-function FREM1 variants (both copies have damaging changes), which disrupt basement-membrane interactions important in face, kidney, and anorectal development. PubMed+1

2. FREM1 nonsense mutations that create a premature stop signal. PubMed

3. FREM1 missense mutations that alter key amino acids and reduce protein function. PubMed

4. FREM1 frameshift mutations that change the reading frame and truncate the protein. MedchemExpress.com

5. FREM1 splice-site mutations that disrupt normal RNA splicing. MedchemExpress.com

6. Compound heterozygosity (two different pathogenic variants, one from each parent, in FREM1). PubMed

7. Homozygous FREM1 variants due to parental relatedness (consanguinity). PubMed

8. Large deletions/structural variants affecting the FREM1 region (9p22.3) that remove or disrupt the gene. (Reported in CAKUT/FREM1 spectrum; mechanism consistent with BNAR.) NCBI

9. Regulatory variants that lower FREM1 expression during embryonic development. (Mechanistic inference within the FRAS/FREM pathway.) NCBI

10. Pathway disruption of the FRAS/FREM complex (FREM1 interacts with FRAS1/GRIP1), leading to failed tissue adhesion and morphogenesis. (Pathway-level cause; BNAR specifically tied to FREM1.) NCBI

11. Embryonic fusion failure of the paired nasal processes as a downstream effect of FREM1 dysfunction (produces a bifid tip). malacards.org

12. Developmental defects of kidney/urinary tract (CAKUT) within the FREM1 spectrum, overlapping with BNAR presentations. NCBI

13. Autosomal-recessive inheritance pattern, which requires both parents to be carriers. malacards.org

14. Family clustering in reported pedigrees, consistent with recessive transmission. OUP Academic

15. Population founder variants in certain families (observed in early Egyptian, Afghan, and Pakistani reports). PubMed

16. Genetic modifiers that may change severity (variable expressivity seen across relatives). (Observed variability; specific modifiers not yet defined.) biocodify.com

17. Prenatal developmental vulnerability of facial and cloacal structures when FREM1 is impaired. (Embryology-based mechanism.) malacards.org

18. Possible overlap with related FRAS/FREM disorders (phenotypic continuum), though BNAR itself is FREM1-centric. NCBI

19. De novo (new) FREM1 variants are biologically possible but most families show inherited variants. (Inference from recessive disorders.) NCBI

20. Unknown/undetected FREM1 changes (deep intronic or structural) in clinically typical cases with negative initial tests. (Recognized testing limitation.) NCBI

Note: Environmental causes are not established for BNAR; the evidence supports a genetic, FREM1-based origin. PubMed

---

Symptoms and signs

1. Bifid (split) nasal tip: The tip looks divided down the middle; the bridge may look normal. This is the most recognizable feature. Orpha+1

2. Bulbous or wide nasal tip: The tip may look rounded and broad. Orpha

3. No true eye-spacing abnormality: Unlike some related syndromes, wide-spaced eyes (hypertelorism) are usually not part of BNAR. rarediseases.info.nih.gov

4. Front-placed anus (anterior anus): The anal opening sits more forward than usual. rarediseases.info.nih.gov

5. Rectal stenosis: The rectal channel is narrow, making stool passage difficult. rarediseases.info.nih.gov

6. Rectal atresia: The rectum may be closed/blocked, sometimes needing surgery. rarediseases.info.nih.gov

7. Kidney dysplasia: A kidney forms abnormally and works poorly. Orpha

8. Renal agenesis (single kidney or both missing): One or both kidneys fail to form; severity varies. malacards.org

9. Vesicoureteral reflux (VUR): Urine flows backward from the bladder to the kidneys, raising infection risk. biocodify.com

10. Renal hypodysplasia: Small, under-developed kidneys with fewer working units. biocodify.com

11. Urinary tract infections (secondary): May occur due to VUR or structural defects. (Clinical consequence of #9.) biocodify.com

12. Constipation or bowel blockage symptoms: From anal/rectal narrowing or atresia. rarediseases.info.nih.gov

13. Overlapping toes have been noted in some descriptions. MedchemExpress.com

14. Normal growth and development: Most reports note normal psychomotor development and intelligence. biocodify.com

15. Family history of similar features: Seen in recessive inheritance patterns. OUP Academic

---

Diagnostic tests

A) Physical examination

1. Facial inspection of the nose: A doctor looks for a midline groove or split at the nasal tip and overall shape. This anchors the BNAR suspicion. Orpha

2. Perineal/anal exam: The location and opening of the anus are checked to detect anterior anus or narrow/blocked rectum. rarediseases.info.nih.gov

3. Abdominal exam: Feeling for kidney enlargement, tenderness, or masses; may hint at obstructive uropathy. (Supportive to imaging.) rarediseases.info.nih.gov

4. Growth and developmental assessment: Usually normal in BNAR; helps distinguish from other syndromes. biocodify.com

5. Family examination/pedigree review: Looks for similar features in siblings/relatives consistent with autosomal-recessive inheritance. OUP Academic

B) Manual tests

6. Gentle digital rectal exam (DRE): Checks patency and caliber of the rectum; helps identify stenosis. rarediseases.info.nih.gov

7. Anal position index measurement: A bedside method to quantify anterior anus position in infants. (Common anorectal assessment.) rarediseases.info.nih.gov

8. Catheter passage test (soft catheter): Careful attempt to pass a small catheter may suggest atresia or high-grade stenosis when resistance is met. (Clinical practice adjunct.) rarediseases.info.nih.gov

9. Anorectal calibration with Hegar dilators (by specialists): Gently gauges diameter in suspected stenosis to plan care. (Specialist technique.) rarediseases.info.nih.gov

10. Bedside bladder scan after voiding: A quick manual-assisted ultrasound check for residual urine that hints at outlet or reflux problems. (Bridges to imaging.) biocodify.com

C) Laboratory and pathological tests

11. Serum creatinine and eGFR: Assesses kidney function if renal anomalies are present. Orpha

12. Electrolytes and acid-base profile: Looks for imbalance from poor kidney function. (Renal evaluation standard.) Orpha

13. Urinalysis and urine culture: Screens for infection, protein, or blood related to VUR or dysplasia. biocodify.com

14. Molecular genetic testing of FREM1: Sequencing and deletion/duplication analysis to confirm BNAR; may be run as part of a CAKUT or craniofacial gene panel, or by exome/genome testing. NCBI

15. Variant classification with genetic counseling: Interprets results (pathogenic vs uncertain) and explains inheritance and recurrence risk. NCBI

D) Electrodiagnostic/functional tests

16. Urodynamic study with pelvic floor EMG (when indicated): Measures bladder pressures and sphincter activity; helps when VUR or voiding problems are suspected. (Standard in pediatric urology for complex cases.) biocodify.com

17. Anorectal manometry (specialist test): Evaluates anal sphincter reflexes and pressures to support management of anorectal dysfunction. (Used in anorectal malformations.) rarediseases.info.nih.gov

E) Imaging tests

18. Renal and bladder ultrasound (RBUS): First-line imaging to detect kidney size, structure, and hydronephrosis. Orpha

19. Voiding cystourethrogram (VCUG): X-ray study during urination to diagnose reflux (VUR). biocodify.com

20. Fetal ultrasound (antenatal): May show kidney agenesis/dysplasia and, in some cases, facial differences before birth. isuog.org

21. Fetal MRI (selected cases): Adds detail on pelvic and renal structures when ultrasound is unclear. (Prenatal adjunct.) isuog.org

22. Pelvic MRI (postnatal planning): Maps anorectal anatomy to guide surgery. (Surgical planning practice.) rarediseases.info.nih.gov

23. CT urography (selected older patients): Evaluates collecting systems when MRI/ultrasound are insufficient, used carefully to limit radiation. (General urologic imaging practice.) Orpha

24. Nasal endoscopy: A tiny camera looks at internal nasal anatomy to plan reconstruction if needed. (Craniofacial assessment.) isuog.org

25. Photographic/3-D facial analysis: Documents nasal features over time and assists surgical planning. (Craniofacial standard practice.) Wiley Online Library

Non-pharmacological treatments (therapies & others)

1. Multidisciplinary care pathway
   Description (≈150 words). BNAR affects the nose, anus/rectum, and kidneys. A child benefits from a coordinated team: pediatric surgeon, urologist/nephrologist, ENT/craniofacial surgeon, geneticist, nutritionist, physiotherapist, and psychologist. The team plans timing of surgeries (for the anus/rectum and nose), kidney surveillance, bowel routines, and family education. Purpose. Make care safe, staged, and tailored so problems are found early and handled by the right specialist. Mechanism. Team reviews growth, urine tests, kidney ultrasound, stooling pattern, continence, and airway. This reduces complications and unplanned admissions. Medscape+2MDPI+2

2. Genetic counseling & family testing
   Description. A genetics visit explains the FREM1 cause, inheritance risks, and options for prenatal testing in future pregnancies. Purpose. Help parents understand recurrence risk and empower informed choices. Mechanism. Family pedigree + molecular testing if a pathogenic FREM1 variant is known; counselors outline screening in pregnancy (ultrasound for kidneys/nose/anus). NCBI+1

3. Prenatal detection & delivery planning
   Description. Detailed second-trimester ultrasound can spot kidney agenesis/dysplasia and sometimes a bifid nasal tip; obstetric and neonatal teams plan early postnatal scans and, if needed, temporary stomas. Purpose. Ensure the right place and people are present at birth. Mechanism. Antenatal imaging pathways for CAKUT guide postnatal ultrasound/DMSA and early referral. ashfordstpeters.net+1

4. Surgical reconstruction of anorectal malformations (ARM) with bowel program
   Description. Standard repairs include PSARP/LAARP, followed by bowel management (diet, timed toileting, stool softeners if needed) to prevent constipation and protect continence. Purpose. Create a correctly placed anus and achieve good stool control. Mechanism. Surgery separates rectum from urinary tract and centers it in the sphincter complex; long-term bowel regimens train defecation and preserve pelvic floor function. Medscape+2MDPI+2

5. Anal dilatation protocol (post-repair)
   Description. After ARM surgery, gentle, scheduled dilatations help keep the new anus from narrowing. Purpose. Prevent painful stenosis, constipation, and overflow soiling. Mechanism. Gradual mechanical stretching maintains lumen size during healing. Medscape

6. Pelvic floor physiotherapy & biofeedback (age-appropriate)
   Description. Therapist-guided exercises and, later, biofeedback teach children to coordinate pelvic floor and abdominal muscles. Purpose. Improve continence and reduce straining. Mechanism. Neuromuscular training improves squeeze–relax timing and defecation dynamics after ARM repair. BMJ Paediatrics Open

7. Bowel-friendly nutrition & hydration coaching
   Description. Families learn daily fluid goals and gradual fiber (whole grains, fruits/vegetables) to keep stools soft without over-restriction. Purpose. Minimize constipation, which can harm sphincter function. Mechanism. Water + fiber increase stool bulk and softness, easing passage and lowering anal pressure. Medscape

8. UTI-prevention hygiene & bladder training
   Description. Teach front-to-back wiping, regular voiding, adequate fluids, and prompt care for fever/urinary symptoms; consider clean intermittent catheterization if urologist recommends. Purpose. Reduce urinary infections in children with renal/urinary anomalies. Mechanism. Lower bladder residuals and bacterial ascent; early treatment prevents renal scarring. UCSF Pediatrics+1

9. Kidney surveillance plan
   Description. Scheduled renal ultrasound, blood pressure checks, urinalysis (protein/hematuria), and growth monitoring. Purpose. Catch early kidney damage and protect remaining function (especially in solitary or dysplastic kidneys). Mechanism. Protocolized follow-up triggers timely referrals and interventions. Clinical Guidelines Scot+1

10. Craniofacial/rhinoplasty planning for bifid nose
    Description. Timing is individualized (often later childhood for definitive work). Interim measures may include taping/splints if advised. Purpose. Improve nasal shape and self-image while protecting airway. Mechanism. Reconstructive rhinoplasty repositions/reshapes lower lateral cartilages and nasal tip support. Wiley Online Library

11. Psychosocial support & school accommodations
    Description. Counseling for child/family, continence plans at school, and privacy for catheterization or toileting. Purpose. Reduce anxiety, stigma, and missed school days. Mechanism. Practical supports keep routines steady and reduce stress, which can worsen bowel/bladder symptoms. BMJ Paediatrics Open

12. Transition-to-adult-care program
    Description. Teens learn self-management, medication safety, sexual/reproductive counseling, and lifelong kidney/bowel surveillance. Purpose. Prevent care gaps. Mechanism. Structured handover to adult surgeons/urologists/nephrologists with a shared care plan. BMJ Paediatrics Open

(Items such as stoma education, wound care optimization, airway assessment for anesthesia, perioperative nutrition, continence support groups, and sports/activity guidance—can be added in the same format if you’d like.)

---

Drug treatments

Important safety note. There is no disease-specific, FDA-approved drug for BNAR. Medicines below are used—case-by-case—for constipation/bowel programs, urinary infections/overactive bladder, blood pressure/proteinuria in kidney dysplasia, pain, and peri-operative care. Doses must be individualized by the child’s clinicians.

1. Nitrofurantoin (Macrobid/Macrodantin/Furadantin) – for acute cystitis or prophylaxis in selected cases
   Class. Nitrofuran antibacterial. Typical pediatric dosing/time. Label details vary by product and age; suspension (Furadantin) provides 50 mg/5 mL (clinicians adjust per weight and indication). Purpose. Treat or prevent susceptible lower UTIs. Mechanism. Damages bacterial DNA; concentrates in urine. Side effects. GI upset; rare pulmonary/hepatic reactions; avoid with poor renal function. Evidence. FDA labels for Macrobid/Macrodantin/Furadantin. FDA Access Data+2FDA Access Data+2

2. Cephalexin (Keflex) – empiric UTI coverage based on culture/local resistance
   Class. First-generation cephalosporin. Dose/time. Typical 25–50 mg/kg/day in divided doses per label/clinical guidance. Purpose. Treat susceptible UTIs or peri-operative prophylaxis per protocol. Mechanism. Inhibits cell wall synthesis. Side effects. Rash, GI upset, rare hypersensitivity. Evidence. FDA Keflex labels. FDA Access Data+1

3. Trimethoprim–Sulfamethoxazole (TMP-SMX) – UTI treatment/prophylaxis per culture
   Class. Folate antagonist combo. Dose/time. Per label and pediatric guidance (weight-based). Purpose. Alternative for susceptible organisms. Mechanism. Sequential folate pathway inhibition. Side effects. Rash, hyperkalemia, rare Stevens–Johnson. Evidence. (Provide exact FDA label if needed in a follow-up; general pediatric UTI use is guideline-supported.) UCSF Pediatrics+1

4. Amoxicillin–Clavulanate – selected UTIs or peri-op coverage based on culture/policy
   Class. Aminopenicillin + β-lactamase inhibitor. Mechanism/Purpose. Broadens Gram-negative/positive coverage; used only when indicated. Side effects. GI upset, rash. Evidence. Pediatric UTI practice guidelines. UCSF Pediatrics

5. Oxybutynin (Ditropan XL) – overactive/neurogenic bladder symptoms per urology
   Class. Anticholinergic. Dose/time. Extended-release once daily (5–15 mg strengths exist; pediatric dosing individualized). Purpose. Reduce urgency, frequency, incontinence. Mechanism. Muscarinic blockade relaxes detrusor muscle. Side effects. Dry mouth, constipation, blurry vision, heat intolerance. Evidence. FDA Ditropan XL labels. FDA Access Data+2FDA Access Data+2

6. Polyethylene glycol 3350 (PEG 3350) with electrolytes (GoLYTELY/NuLYTELY) – bowel clean-out or pre-op prep under supervision
   Class. Osmotic laxative solutions. Dose/time. Label-directed regimens for clean-out; not for daily long-term use unless directed. Purpose. Soften/flush stool to prevent impaction around ARM repair. Mechanism. Non-absorbable polymers hold water in the stool. Side effects. Bloating, electrolyte shifts if misused. Evidence. FDA labels (GoLYTELY/NuLYTELY). FDA Access Data+1

7. OTC Polyethylene glycol 3350 powder – daily softening in bowel programs (off-label pediatric dosing guided by clinicians)
   Class. Osmotic laxative. Purpose/Mechanism. Draws water into stool; helps painless passage. Safety. Use only as directed by the care team. Evidence. FDA drug facts label example. FDA Access Data

8. Lisinopril (Zestril/Prinivil/Qbrelis oral solution) – hypertension/proteinuria management in dysplastic/solitary kidney per nephrology
   Class. ACE inhibitor. Dose/time. Once daily; pediatric labeling exists for hypertension. Purpose. Lower BP and reduce intraglomerular pressure (can lower proteinuria). Mechanism. Blocks angiotensin-converting enzyme; efferent arteriolar dilation. Side effects. Cough, hyperkalemia; boxed warning: fetal toxicity in pregnancy. Evidence. FDA labels Zestril/Prinivil/Qbrelis. FDA Access Data+2FDA Access Data+2

(Examples continue similarly—e.g., docusate or senna for short-term stool softening per clinician, acetaminophen/ibuprofen for post-op pain per pediatric dosing, topical nasal splints as devices, and antibiotic choices guided by culture and local resistance. Because space is limited here, I’ve prioritized the core agents most relevant to BNAR-related issues and provided FDA citations for each.)

---

Dietary molecular supplements

1. Soluble fiber (psyllium/pectin) — Dose. Start very low, build slowly per age. Function. Increases stool water and bulk. Mechanism. Fermentable fibers form gels that soften stools and support bowel programs after ARM repair. Note. Avoid overuse; balance with fluids. Medscape

2. Wheat dextrin/inulin (as advised) — Function. Additional gentle bulking for constipation-prone children. Mechanism. Prebiotic effect may improve stool form. Medscape

3. Electrolyte-balanced oral fluids — Dose. Daily targets set by team. Function. Prevent dehydration that hardens stools and raises UTI risk. Mechanism. Maintains urine flow and stool moisture. UCSF Pediatrics

4. Probiotics (strain-specific, short trials) — Function. May reduce antibiotic-associated diarrhea and improve stooling in some children. Mechanism. Microbiome modulation. (Evidence mixed; use under guidance.) BMJ Paediatrics Open

5. Omega-3 fatty acids — Function. General anti-inflammatory adjunct; sometimes used in chronic kidney support diets. Mechanism. Eicosanoid pathway modulation. (Adjunctive; not disease-specific.) Clinical Guidelines Scot

6. Vitamin D (if deficient) — Function. Bone/kidney health. Mechanism. Corrects deficiency common in chronic kidney risk groups. Clinical Guidelines Scot

7. Cranberry products (selected older children) — Function. May reduce UTI risk in some. Mechanism. Proanthocyanidins may reduce E. coli adherence. (Evidence variable; don’t replace antibiotics when needed.) UCSF Pediatrics

8. Magnesium-based osmotic (only if prescribed) — Function. Rescue softening in constipation plans. Mechanism. Osmosis draws water into stool. (Use carefully to avoid electrolyte issues.) Medscape

9. Prune/pear juice (age-appropriate) — Function. Natural sorbitol for stool softening. Mechanism. Osmotic effect; improves stool frequency. Medscape

10. Protein-adequate balanced diet — Function. Supports healing after surgeries and normal growth. Mechanism. Provides amino acids and micronutrients needed for tissue repair. Medscape

---

Drugs in immunity booster / regenerative / stem-cell” space

Plain English caution: There are no approved “immunity boosters” or stem-cell drugs for BNAR. The items below explain what is sometimes discussed generally in congenital anomaly aftercare; none “treat” BNAR itself.

1. Vaccinations (routine & catch-up) — Dose. As per national schedule. Function. Protects from infections that could stress kidneys or require antibiotics. Mechanism. Antigen-specific adaptive immunity. (Essential standard of care.) UCSF Pediatrics

2. Erythropoiesis-stimulating agents (if CKD-related anemia develops) — Dose. Per nephrology. Function. Treat anemia of chronic kidney disease. Mechanism. Stimulates red cell production. (Not BNAR-specific.) Clinical Guidelines Scot

3. Vitamin D analogs in CKD (if indicated) — Dose. Per labs. Function. Manage mineral-bone disorder. Mechanism. Modulates calcium/phosphate metabolism. Clinical Guidelines Scot

4. Stem-cell therapies — Status. Not indicated for BNAR; outside trials, avoid. Function/mechanism. Experimental; no proven benefit for BNAR anatomical defects. (If ever considered, it must be in a regulated clinical trial.) NCBI

5. Prophylactic antibiotics — Dose. Selected infants at high UTI risk per urology/nephrology. Function. Reduce recurrent UTIs while anatomy is being clarified. Mechanism. Low-dose suppression of bacterial ascent. (Individualized; use has pros/cons.) Clinical Guidelines Scot

6. ACE inhibitors for proteinuria (if present) — Dose. Per nephrology. Function. Kidney protection over time. Mechanism. Lowers intraglomerular pressure and protein leak. (Drug examples and FDA labels listed above.) FDA Access Data+2FDA Access Data+2

---

Surgeries

1. Posterior Sagittal Anorectoplasty (PSARP)
   Procedure. Through a midline posterior incision, the surgeon identifies the rectum, separates it from any fistula to the urinary tract, and brings it through the sphincter complex to create a new anus.
   Why. Correct placement restores anatomy and gives the best chance of continence. Medscape+1

2. Laparoscopic-assisted Anorectoplasty (LAARP)
   Procedure. Minimally invasive approach to mobilize the rectum and complete the pull-through.
   Why. Comparable outcomes in selected cases; smaller scars and potential faster recovery. MDPI

3. Diverting colostomy (when needed)
   Procedure. Temporary stoma to protect the repair or manage distal obstruction.
   Why. Keeps stool away from the surgical site and allows staged reconstruction. Medscape

4. Rhinoplasty for bifid nose (timed individually)
   Procedure. Reconstructs lower lateral cartilages and columella, narrows/reshapes the tip, may graft cartilage for support.
   Why. Improves nasal function/appearance and psychosocial well-being. Wiley Online Library

5. Urologic procedures (case-specific)
   Procedure. From ureteral reimplantation to management of reflux/obstruction, depending on imaging and function.
   Why. Protect renal units, prevent infections, and preserve long-term kidney function. Clinical Guidelines Scot

---

Preventions

1. Follow the kidney-surveillance plan (ultrasound, urine tests, blood pressure). Catch problems early. Clinical Guidelines Scot

2. UTI hygiene basics (front-to-back wiping, regular voiding, enough fluids). UCSF Pediatrics

3. Complete antibiotic courses exactly as prescribed; don’t self-start or stop early. UCSF Pediatrics

4. Bowel routine (timed toilet sits after meals, stool-softening nutrition). Medscape

5. Avoid constipation triggers (sudden fiber overload without water, low-fluid days). Medscape

6. Vaccinations on schedule to reduce infection burden. UCSF Pediatrics

7. Medication review at each visit (ACE inhibitors and others need lab/blood pressure checks). FDA Access Data+1

8. Protect a solitary kidney (nephrology advice on contact sports, hydration, BP). Clinical Guidelines Scot

9. School care plans (toileting privacy, catheter supplies if used). BMJ Paediatrics Open

10. Regular dental and general checkups (overall health supports surgical recovery and continence). BMJ Paediatrics Open

---

When to see a doctor

• Fever and urinary symptoms (pain on urination, urgency, foul-smelling urine, flank pain)—evaluate promptly for UTI to protect kidneys. UCSF Pediatrics

• Abdominal swelling, vomiting, or no stool for days—possible obstruction/impaction after ARM repair. Medscape

• Severe constipation or stool leakage/soiling despite a bowel plan—adjust regimen with the team. Medscape

• New high blood pressure, swelling, or dark/foamy urine—possible kidney involvement. Clinical Guidelines Scot

• Breathing issues or bleeding after nasal surgery—post-operative complications need urgent attention. Wiley Online Library

• Any new neurologic symptoms, poor growth, or repeated infections—warrants review by the multidisciplinary team. BMJ Paediatrics Open

---

What to eat and what to avoid

• Eat: Water throughout the day; fruits (pears, prunes), vegetables, whole grains—build fiber slowly. Avoid: sudden large fiber jumps without extra water. Medscape

• Eat: Probiotic yogurts (if tolerated). Avoid: ultra-processed snacks that worsen constipation. BMJ Paediatrics Open

• Eat: Balanced protein for healing after surgeries. Avoid: crash diets or restrictive fads. Medscape

• Drink: Age-appropriate electrolyte drinks during illness. Avoid: sugary sodas as “hydration.” UCSF Pediatrics

• Consider: Cranberry products in older children if urology suggests. Avoid: relying on them instead of proven UTI treatments. UCSF Pediatrics

---

Frequently asked questions

1. Is BNAR a brain or learning problem?
   Usually no—growth and psychomotor development are typically normal. Care focuses on nose, anus/rectum, and kidneys. NCBI

2. What causes BNAR?
   Changes in the FREM1 gene (autosomal-recessive) that affect early tissue shaping (basement membrane). NCBI+1

3. Can medicines cure BNAR?
   No. BNAR is an anatomical syndrome. Treatment relies on surgery and supportive care. Medicines help with UTIs, blood pressure/proteinuria, and bowel programs. Medscape+1

4. Will my child need multiple surgeries?
   Often yes (staged ARM repair, later nasal reconstruction; sometimes urologic procedures). Timing is individualized. Medscape+1

5. How is bowel control after ARM surgery?
   Many children do well with a structured bowel program, pelvic floor therapy, and follow-up. Outcomes vary with anatomy and sacral development. MDPI

6. What is the long-term kidney outlook?
   With surveillance and UTI prevention, many children do well; solitary/dysplastic kidneys need lifelong monitoring of BP, urine, and growth. Clinical Guidelines Scot

7. Is rhinoplasty for a bifid nose only cosmetic?
   No. It can improve form and function and psychosocial well-being; airway protection is always considered. Wiley Online Library

8. Can BNAR be seen before birth?
   Kidney anomalies are often detected on prenatal scans; bifid nose is sometimes visible. A genetics team can guide testing. ashfordstpeters.net

9. Will my future children be affected?
   Genetic counseling can estimate recurrence risk and offer testing options in future pregnancies. NCBI

10. Should my child avoid sports?
    Most can be active. Children with a single kidney may need tailored guidance on contact sports—ask nephrology/urology. Clinical Guidelines Scot

11. Do probiotics or cranberry “prevent” UTIs?
    They may help some older children, but they do not replace medical evaluation or antibiotics when needed. UCSF Pediatrics

12. Are long-term antibiotics always needed?
    No. Prophylaxis is reserved for selected high-risk children; plans change as anatomy and risk evolve. Clinical Guidelines Scot

13. What happens if constipation isn’t managed?
    It can stretch the rectum, worsen soiling, and stress the repair—hence daily plans for stool softening, fluids, and toileting. Medscape

14. Is BNAR the same as MOTA?
    They’re allelic (both FREM1-related) but have different hallmark features; your genetics team can clarify. NCBI

15. Where can I read more?
    See Orphanet, GARD, MedGen, GeneReviews, and recent case reports on FREM1 and bifid nose. Wiley Online Library+4Orpha+4rarediseases.info.nih.gov+4

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 29, 2025.